News
Researchers at the Pennington Biomedical Research Center have found new clues about how the drug tirzepatide, also known by ...
Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...
The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.
4h
Zacks.com on MSNIs Eli Lilly Stock a Portfolio Must-Have Pre-Q2 Earnings?Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.62 billion and $3.52 per share, ...
Mounjaro, the new weight loss drug, is gaining popularity in India for its rapid results. Patients report better appetite control, blood sugar management, and significant weight loss.
BORDERLINE alcoholic’ Shane Harding claims King Kong weight loss jab Mounjaro helped her shed six stone by curbing her ...
Tariff wars and macro woes have impacted investor sentiment, weighing on stocks across various sectors. However, healthcare ...
A PRESENTER has candidly opened up on her “absolutely horrendous” experience while using Mounjaro. Danielle Mason, an ...
Seizures of potentially dangerous weight loss drugs being sold on the black market in Scotland have soared as online dealers ...
We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results